Teva Ruling Offers Patentees New Support For Genus Claims
On April 16, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, reversing the U.S. District Court...To view the full article, register now.
Already a subscriber? Click here to view full article